Celera Genomics Appoints Lothar Krinke as Vice President, Business Development and Strategic Planning

Business Wire, March 20, 2001

Business Editors/Health & Medical Writers

ROCKVILLE, Md.--(BW HealthWire)--March 20, 2001

Celera Genomics (NYSE:CRA), an Applera Corporation business announced today that Lothar Krinke has been appointed vice president, business development and strategic planning.

In this new position, Mr. Krinke's focus will be on business development and potential mergers and acquisitions directed towards Celera's Discovery Sciences strategy and the expansion of the group's Information business.

Previously, Mr. Krinke was at A.T. Kearney Inc., a global management consulting firm, where he was a vice president in the pharmaceutical practice responsible for helping biopharmaceutical companies to develop research and development and marketing strategies. Prior to that he worked at McKinsey & Company, another leading management consulting firm.

Mr. Krinke obtained his undergraduate degree in biology from Technische Universitaet Braunschweig in Germany and his Ph.D. in molecular biology from the State University of New York at Albany. He also held an American Cancer Society Postdoctoral Fellowship at the California Institute of Technology.

Applera Corporation, formerly PE Corporation, comprises two operating groups. The Celera Genomics Group, headquartered in Rockville, MD, is a definitive source of genomic and related medical information. Celera has developed three business units: the On-line Information Business, Discovery Sciences, and Discovery Services, all of which build upon Celera's generation, integration, and analysis of biological information. Celera intends to enable therapeutic discoveries both through its own application of its scientific capabilities and in partnership with pharmaceutical and biotechnology companies. The Applied Biosystems Group (NYSE:ABI) develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community. Customers use these tools to analyze nucleic acids (DNA and RNA) and proteins in order to make scientific discoveries, develop new pharmaceuticals, and conduct standardized testing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.4 billion during fiscal 2000. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available on the World Wide Web at www.applera.com, or by telephoning 800/762-6923.